HealthEquity (FRA:2HE) ROCE %: 13.17% (As of Apr. 2026)


FRA:2HE HealthEquity Inc FRA:2HE
92 GF Score
Price €72.00
GF Value €83.82
! 1 Warning Sign
View Full Analysis

What is HealthEquity ROCE %?

HealthEquity FRA:2HE -4.00% 92 ROCE % is 13.17% as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 92/100 and a GF Value™ of €83.82. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HealthEquity's annualized ROCE % for the quarter that ended in Apr. 2026 was 13.17%.

HealthEquity  (FRA:2HE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HealthEquity ROCE % Related Terms

HealthEquity ROCE % Historical Data

* Premium members only.

The historical data trend for HealthEquity's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity ROCE % Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.14 0.36 4.32 5.71 9.61

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.99 11.06 9.93 9.08 13.17
FRA:2HE
92GF Score
HealthEquity Inc FRA:2HE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity ROCE % Calculation

HealthEquity's annualized ROCE % for the fiscal year that ended in Jan. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=284.713/( ( (3331.299 - 151.008) + (2876.663 - 133.479) )/ 2 )
=284.713/( (3180.291+2743.184)/ 2 )
=284.713/2961.7375
=9.61 %

HealthEquity's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=359.104/( ( (2876.663 - 133.479) + (2826.789 - 116.058) )/ 2 )
=359.104/( ( 2743.184 + 2710.731 )/ 2 )
=359.104/2726.9575
=13.17 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.17% mean?
HealthEquity (FRA:2HE) has a ROCE % of 13.17% as of Apr. 2026.
Is HealthEquity's ROCE % too high?
HealthEquity's current ROCE % is 13.17%. The Healthcare Providers & Services industry median ROCE % is 6.43. HealthEquity's value of 13.17% is 104.8% above this industry median. Overall, HealthEquity has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's ROCE % compare to HNGE and TEM?
HealthEquity's ROCE % of 13.17% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. HealthEquity's value of 13.17% is 104.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current ROCE % of 13.17% is 104.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current ROCE % is 13.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current ROCE % of 13.17%. The stock's GF Value™ is €83.82, compared to a current price of €72.00 — trading 14.1% below its estimated fair value. The current ROCE % is 13.17% and 104.8% above the Healthcare Providers & Services industry median of 6.43. HealthEquity's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current ROCE % is 13.17% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €72.00 is trading 14.1% below its estimated GF Value™ of €83.82.

Key valuation signals for FRA:2HE:

  • ROCE %: 13.17%
  • GF Value™: €83.82 vs. price of €72.00 (14.1% below fair value)
  • GF Score™: 92/100 with 1 warning sign
  • Industry Position: 104.8% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
92GF Score

Get the complete analysis for FRA:2HE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€72.00
Price
€83.82
GF Value